Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fluticasone Furoate/Vilanterol vs. Umeclidinium/Vilanterol in Patients With COPD-asthma Phenotype vs. Emphysema Phenotype. A Controled Clinical Trial.

NCT05342558 is registered in ClinicalTrials.gov with National Institute of Respiratory Diseases, Mexico as lead sponsor.

NCT NCT05342558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05342558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fluticasone Furoate/Vilanterol vs. Umeclidinium/Vilanterol in Patients With COPD-asthma Phenotype vs. Emphysema Phenotype. A Controled Clinical Trial.
Lead sponsor
National Institute of Respiratory Diseases, Mexico
Phase
Phase 4
Overall status
Completed
Start date
September 19, 2017
Completion date
February 1, 2021
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd